Committee on Energy and Commerce, Democrats Home Page
Who We Are Schedule What's New
View Printable Version




NEWS RELEASE
COMMITTEE ON ENERGY AND COMMERCE DEMOCRATS
Congressman John D. Dingell, Ranking Member


For Immediate Release
April 25, 2002

Contact: Laura Sheehan
202-225-3641

Dingell Unveils SAFE Motherhood Act

Washington, D.C. – Congressman John D. Dingell, Ranking Member of the Committee on Energy and Commerce, today unveiled the Safe Motherhood Act for Research and Treatment or "SMART Mom" to help ensure that women’s critical pregnancy-related health issues are addressed. Dingell was joined by Representative Nita Lowey and Senators Tom Harkin and Barbara Mikulski in introducing the bill.

"As a husband, father of two daughters and a grandfather, I have long been aware of the importance of ensuring that women receive the best health care available," Dingell said. "Unfortunately, pregnancy-related complications that too often result in death or permanent illness largely remain the mystery they were before the advent of modern science."

One out of every three women who give birth in the United States suffers a pregnancy-related complication before, during, or after delivery, potentially causing long-term health problems or even death. In Michigan, 9 infants out of every 1,000 live birth dies from complications of pregnancy.

"It is crucial that we begin to unravel the mystery that surrounds the complications from pregnancy that are prevalent among African American women, which is particularly true in my home state of Michigan," Dingell said. "No stone should be left uncovered in our quest to improve all women’s health care."

To help address these concerns SMART Mom will:

  • Fund aggressive research through National Institute of Child Health and Human Development, Centers for Disease Control and the Agency for Healthcare Research and Quality to improve pregnancy outcomes in a number of areas, including: reducing the rate of maternal morbidity and mortality; eliminating racial and ethnic disparities in maternal health outcomes; and improving the understanding and treatment of chronic conditions, physical impairments or mental health problems of women during pregnancy.
  • Develop improved and more accurate data collection and public health surveillance to help track and reduce pregnancy-related deaths and complications during and after pregnancy.
  • Address both how information about the use of medication during pregnancy and lactation is communicated in drug labeling and increase information and research on the use of drugs and devices during pregnancy and lactation.
  • Expand public health prevention, education and outreach so women have the information necessary to make wise, healthy, and informed decisions about their health during pregnancy.

 

- 30 -


Prepared by the Committee on Energy and Commerce
2125 Rayburn House Office Building, Washington, DC 20515